Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: NUCKS promotes cell proliferation and suppresses autophagy through the mTOR-Beclin1 pathway in gastric cancer

Fig. 1

High expression of NUCKS correlates with poor patient prognosis in human gastric cancer. a The immunohistochemical assays of NUCKS expression in human gastric cancer tumors and adjacent normal tissue (Scale bars, 50 μm). b Box plot of NUCKS expression levels in peritumoral tissues (Normal) and gastric cancer tumors set with the log-rank test P-values < 0.05. c Kaplan-Meier analysis of progression-free survival and the log-rank test P values are indicated for the TCGA dataset (TCGA samples-478). d Kaplan-Meier analysis of progression-free survival and the log-rank test P values are indicated for the TCGA dataset (TCGA samples-407). e Multivariate cox regression analysis of independent predictors of the overall survival of patients with gastric cancer. f, g The qRT-PCR and Western blot assay were performed to detect NUCKS expression in gastric cancer cell lines

Back to article page